2020, January 26-28: Pancreaticobiliary Pathology for Those in the Trenches: What Really Matters (and What Doesn’t)
Jan. 26-28, 2020 - Palm Springs, California
16 CME / 16 SAMs
Every general surgical pathology practice routinely receives gallbladder specimens, yet many pathologists lack sufficient expertise in gallbladder pathology to feel comfortable when confronted with unusual patterns of inflammation such as vasculitis, parasitic infestation and immune-mediated conditions. Gallbladder neoplasms are uncommon and often discovered at the time of histologic examination, provoking angst among surgeons and pathologists who infrequently encounter such cases and may not be aware of updated terminology and staging issues. Widespread use of cross-sectional imaging in the evaluation of patients with abdominal symptoms has led to increased numbers of incidentally discovered pancreaticobiliary lesions. Many of these are initially evaluated with fine needle aspiration biopsy (FNAB) or limited tissue biopsy samples. As a result, pathologists are often faced with cytology, biopsy and resection specimens that feature disorders relatively uncommon to their practices. They may be required to deal with such specimens under pressure, such as in the frozen section laboratory where immunohistochemical stains and other ancillary tools are not available. This course is intended to provide learners with practical information and diagnostic pearls that may aid them in their day-to-day practices. Intimate mentoring with experts at 18-head teaching microscopes reinforces learning and practice improvements.
- Discriminate between carcinoma and its potential mimics in frozen sections and limited biopsy material
- Understand the classification and differential diagnoses of cystic and solid intraductal lesions
- Recognize and classify important inflammatory conditions of the pancreaticobiliary tree
- Develop an algorithmic approach to differential diagnosis of solid pancreaticobiliary tumors
- Generate a differential diagnosis for lesions encountered in cytology specimens
- Rhonda Yantiss, MD
Weill Cornell Medicine
- Wendy L. Frankel, MD
The Ohio State University
- Jose Jessurun, MD
Weill Cornell Medicine
- Martha Bishop Pitman, MD
Massachusetts General Hospital, Harvard Medical School
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Continuing Certification (CC). Physicians can earn a maximum of 16 SAM credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
Cancellations will be assessed an administrative charge of 25% of the total registration fee. There will be no refunds for cancellations within 14 days of the event. The Academy is not responsible for travel expenses incurred as a result of an event cancellation.